Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPG | hg38_v1_chr19_+_33373694_33373826 | -0.28 | 1.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 44.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.0 | 15.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 14.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
4.7 | 14.0 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
1.3 | 11.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
3.8 | 11.4 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.3 | 11.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 11.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 10.0 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.3 | 9.7 | GO:0006825 | copper ion transport(GO:0006825) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 64.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.9 | 39.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 20.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 14.3 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 14.1 | GO:0005796 | Golgi lumen(GO:0005796) |
1.4 | 11.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.0 | 7.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 5.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 4.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 4.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 41.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 32.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 21.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
2.6 | 18.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 14.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 13.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.4 | 11.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 11.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.7 | 9.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 9.1 | GO:0008483 | transaminase activity(GO:0008483) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 25.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 13.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 12.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 12.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 11.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 11.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 11.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 8.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 36.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.8 | 21.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 18.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 11.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 11.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 11.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 9.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 8.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 8.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 4.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |